Biomarkers innovation in urinary tract infections: Insights into pathophysiology, antibiotic resistance, and clinical applications

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Nephrol. Dec 25, 2025; 14(4): 110749
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.110749

Full Size Figure Download Figure

Figure 4 Multiple forms of neutrophil gelatinase-associated lipocalin. NGAL: Neutrophil gelatinase-associated lipocalin.

Citation: Pandey S, Aravaanan ASK, Bhaskar E, Silambanan S. Biomarkers innovation in urinary tract infections: Insights into pathophysiology, antibiotic resistance, and clinical applications. World J Nephrol 2025; 14(4): 110749
URL: https://www.wjgnet.com/2220-6124/full/v14/i4/110749.htm
DOI: https://dx.doi.org/10.5527/wjn.v14.i4.110749

Pandey S, Aravaanan ASK, Bhaskar E, Silambanan S. Biomarkers innovation in urinary tract infections: Insights into pathophysiology, antibiotic resistance, and clinical applications. World J Nephrol 2025; 14(4): 110749 [PMID: 41479814 DOI: 10.5527/wjn.v14.i4.110749]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.